Cyclosporin in less common immune‐mediated skin diseases

T. Ruzicka
DOI: https://doi.org/10.1111/j.1365-2133.1996.tb00709.x
IF: 11.113
1996-09-01
British Journal of Dermatology
Abstract:Cyclosporin represents a major step forward in the systemic treatment of various dermatoses. Psoriasis vulgaris and atopic eczema, the two major indications for the drug, are dealt with elsewhere in this issue. Therefore, this short review will focus on less common inflammatory skin diseases.
What problem does this paper attempt to address?